NCT00413374View on ClinicalTrials.gov

Once Daily Enoxaparin for Outpatient Treatment of Acute DVT and/or Pulmonary Embolism

NACompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

April 30, 2008

Study Completion Date

December 31, 2008

Conditions

Deep Vein ThrombosisPulmonary Embolism

Interventions

DRUG

Enoxaparin

Patient takes 1.5 mg per kilogram, once daily, subcutaneous injections until INR is therapeutic, then medication is stopped.

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Sanofi

INDUSTRY

lead

Brigham and Women's Hospital

OTHER